 | • レポートコード：GIR-22F19137 • 出版社/出版日：GlobalInfoResearch / 2022年11月 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Anti Snake Venom Serum (ASVS) Market 2022」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社の最新の調査によると、世界の抗ヘビ毒血清(ASVS)の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 抗ヘビ毒血清(ASVS)市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次をカバーします。 ・多価、一価 アプリケーション別セグメントは次のように区分されます。 ・病院・診療所、非営利団体 世界の抗ヘビ毒血清(ASVS)市場の主要な市場プレーヤーは以下のとおりです。 ・CSL、Merck、BTG、Pfizer、Haffkine Bio-Pharmaceutical、Rare Disease Therapeutics、Flynn Pharma、Vins Bioproducts、Bharat Serums and Vaccines、Serum Biotech、MicroPharm 地域別セグメントは次の地域・国をカバーします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計15章あります。 ・第1章では、抗ヘビ毒血清(ASVS)製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要な抗ヘビ毒血清(ASVS)メーカーの企業概要、2019年～2022年までの抗ヘビ毒血清(ASVS)の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要な抗ヘビ毒血清(ASVS)メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2017年～2028年までの地域別抗ヘビ毒血清(ASVS)の販売量、売上、成長性を示しています。 ・第5、6章では、2017年～2028年までの抗ヘビ毒血清(ASVS)のタイプ別とアプリケーション別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での抗ヘビ毒血清(ASVS)市場予測を収録しています。 ・第12章では、主要な原材料、主要なサプライヤー、および抗ヘビ毒血清(ASVS)の産業チェーンを掲載しています。 ・第13、14、15章では、抗ヘビ毒血清(ASVS)の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 - 抗ヘビ毒血清(ASVS)の概要 - タイプ別分析（2017年vs2021年vs2028年）：多価、一価 - アプリケーション別分析（2017年vs2021年vs2028年）：病院・診療所、非営利団体 - 世界の抗ヘビ毒血清(ASVS)市場規模・予測 - 世界の抗ヘビ毒血清(ASVS)生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - CSL、Merck、BTG、Pfizer、Haffkine Bio-Pharmaceutical、Rare Disease Therapeutics、Flynn Pharma、Vins Bioproducts、Bharat Serums and Vaccines、Serum Biotech、MicroPharm ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：多価、一価 ・アプリケーション別分析2017年-2028年：病院・診療所、非営利団体 ・抗ヘビ毒血清(ASVS)の北米市場分析 - 抗ヘビ毒血清(ASVS)の北米市場：タイプ別市場規模2017年-2028年 - 抗ヘビ毒血清(ASVS)の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・抗ヘビ毒血清(ASVS)のヨーロッパ市場分析 - ：抗ヘビ毒血清(ASVS)のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：抗ヘビ毒血清(ASVS)のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・抗ヘビ毒血清(ASVS)のアジア太平洋市場分析 - 抗ヘビ毒血清(ASVS)のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 抗ヘビ毒血清(ASVS)のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・抗ヘビ毒血清(ASVS)の南米市場分析 - 抗ヘビ毒血清(ASVS)の南米市場：タイプ別市場規模2017年-2028年 - 抗ヘビ毒血清(ASVS)の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・抗ヘビ毒血清(ASVS)の中東・アフリカ市場分析 - 抗ヘビ毒血清(ASVS)の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 抗ヘビ毒血清(ASVS)の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Anti Snake Venom Serum (ASVS) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Anti Snake Venom Serum (ASVS) market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospitals and Clinics accounting for % of the Anti Snake Venom Serum (ASVS) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Polyvalent segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Anti Snake Venom Serum (ASVS) include CSL, Merck, BTG, Pfizer, and Haffkine Bio-Pharmaceutical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Anti Snake Venom Serum (ASVS) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Polyvalent
Monovalent
Market segment by Application can be divided into
Hospitals and Clinics
Non-profit Institutions
The key market players for global Anti Snake Venom Serum (ASVS) market are listed below:
CSL
Merck
BTG
Pfizer
Haffkine Bio-Pharmaceutical
Rare Disease Therapeutics
Flynn Pharma
Vins Bioproducts
Bharat Serums and Vaccines
Serum Biotech
MicroPharm
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti Snake Venom Serum (ASVS) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Anti Snake Venom Serum (ASVS), with price, sales, revenue and global market share of Anti Snake Venom Serum (ASVS) from 2019 to 2022.
Chapter 3, the Anti Snake Venom Serum (ASVS) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti Snake Venom Serum (ASVS) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Anti Snake Venom Serum (ASVS) market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Anti Snake Venom Serum (ASVS).
Chapter 13, 14, and 15, to describe Anti Snake Venom Serum (ASVS) sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Anti Snake Venom Serum (ASVS) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anti Snake Venom Serum (ASVS) Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Polyvalent
1.2.3 Monovalent
1.3 Market Analysis by Application
1.3.1 Overview: Global Anti Snake Venom Serum (ASVS) Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals and Clinics
1.3.3 Non-profit Institutions
1.4 Global Anti Snake Venom Serum (ASVS) Market Size & Forecast
1.4.1 Global Anti Snake Venom Serum (ASVS) Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Anti Snake Venom Serum (ASVS) Sales in Volume (2017-2028)
1.4.3 Global Anti Snake Venom Serum (ASVS) Price (2017-2028)
1.5 Global Anti Snake Venom Serum (ASVS) Production Capacity Analysis
1.5.1 Global Anti Snake Venom Serum (ASVS) Total Production Capacity (2017-2028)
1.5.2 Global Anti Snake Venom Serum (ASVS) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Anti Snake Venom Serum (ASVS) Market Drivers
1.6.2 Anti Snake Venom Serum (ASVS) Market Restraints
1.6.3 Anti Snake Venom Serum (ASVS) Trends Analysis
2 Manufacturers Profiles
2.1 CSL
2.1.1 CSL Details
2.1.2 CSL Major Business
2.1.3 CSL Anti Snake Venom Serum (ASVS) Product and Services
2.1.4 CSL Anti Snake Venom Serum (ASVS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Anti Snake Venom Serum (ASVS) Product and Services
2.2.4 Merck Anti Snake Venom Serum (ASVS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 BTG
2.3.1 BTG Details
2.3.2 BTG Major Business
2.3.3 BTG Anti Snake Venom Serum (ASVS) Product and Services
2.3.4 BTG Anti Snake Venom Serum (ASVS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer Anti Snake Venom Serum (ASVS) Product and Services
2.4.4 Pfizer Anti Snake Venom Serum (ASVS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Haffkine Bio-Pharmaceutical
2.5.1 Haffkine Bio-Pharmaceutical Details
2.5.2 Haffkine Bio-Pharmaceutical Major Business
2.5.3 Haffkine Bio-Pharmaceutical Anti Snake Venom Serum (ASVS) Product and Services
2.5.4 Haffkine Bio-Pharmaceutical Anti Snake Venom Serum (ASVS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Rare Disease Therapeutics
2.6.1 Rare Disease Therapeutics Details
2.6.2 Rare Disease Therapeutics Major Business
2.6.3 Rare Disease Therapeutics Anti Snake Venom Serum (ASVS) Product and Services
2.6.4 Rare Disease Therapeutics Anti Snake Venom Serum (ASVS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Flynn Pharma
2.7.1 Flynn Pharma Details
2.7.2 Flynn Pharma Major Business
2.7.3 Flynn Pharma Anti Snake Venom Serum (ASVS) Product and Services
2.7.4 Flynn Pharma Anti Snake Venom Serum (ASVS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Vins Bioproducts
2.8.1 Vins Bioproducts Details
2.8.2 Vins Bioproducts Major Business
2.8.3 Vins Bioproducts Anti Snake Venom Serum (ASVS) Product and Services
2.8.4 Vins Bioproducts Anti Snake Venom Serum (ASVS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Bharat Serums and Vaccines
2.9.1 Bharat Serums and Vaccines Details
2.9.2 Bharat Serums and Vaccines Major Business
2.9.3 Bharat Serums and Vaccines Anti Snake Venom Serum (ASVS) Product and Services
2.9.4 Bharat Serums and Vaccines Anti Snake Venom Serum (ASVS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Serum Biotech
2.10.1 Serum Biotech Details
2.10.2 Serum Biotech Major Business
2.10.3 Serum Biotech Anti Snake Venom Serum (ASVS) Product and Services
2.10.4 Serum Biotech Anti Snake Venom Serum (ASVS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 MicroPharm
2.11.1 MicroPharm Details
2.11.2 MicroPharm Major Business
2.11.3 MicroPharm Anti Snake Venom Serum (ASVS) Product and Services
2.11.4 MicroPharm Anti Snake Venom Serum (ASVS) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Anti Snake Venom Serum (ASVS) Breakdown Data by Manufacturer
3.1 Global Anti Snake Venom Serum (ASVS) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Anti Snake Venom Serum (ASVS) Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Anti Snake Venom Serum (ASVS)
3.4 Market Concentration Rate
3.4.1 Top 3 Anti Snake Venom Serum (ASVS) Manufacturer Market Share in 2021
3.4.2 Top 6 Anti Snake Venom Serum (ASVS) Manufacturer Market Share in 2021
3.5 Global Anti Snake Venom Serum (ASVS) Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Anti Snake Venom Serum (ASVS) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Anti Snake Venom Serum (ASVS) Market Size by Region
4.1.1 Global Anti Snake Venom Serum (ASVS) Sales in Volume by Region (2017-2028)
4.1.2 Global Anti Snake Venom Serum (ASVS) Revenue by Region (2017-2028)
4.2 North America Anti Snake Venom Serum (ASVS) Revenue (2017-2028)
4.3 Europe Anti Snake Venom Serum (ASVS) Revenue (2017-2028)
4.4 Asia-Pacific Anti Snake Venom Serum (ASVS) Revenue (2017-2028)
4.5 South America Anti Snake Venom Serum (ASVS) Revenue (2017-2028)
4.6 Middle East and Africa Anti Snake Venom Serum (ASVS) Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Anti Snake Venom Serum (ASVS) Sales in Volume by Type (2017-2028)
5.2 Global Anti Snake Venom Serum (ASVS) Revenue by Type (2017-2028)
5.3 Global Anti Snake Venom Serum (ASVS) Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Anti Snake Venom Serum (ASVS) Sales in Volume by Application (2017-2028)
6.2 Global Anti Snake Venom Serum (ASVS) Revenue by Application (2017-2028)
6.3 Global Anti Snake Venom Serum (ASVS) Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Anti Snake Venom Serum (ASVS) Sales by Type (2017-2028)
7.2 North America Anti Snake Venom Serum (ASVS) Sales by Application (2017-2028)
7.3 North America Anti Snake Venom Serum (ASVS) Market Size by Country
7.3.1 North America Anti Snake Venom Serum (ASVS) Sales in Volume by Country (2017-2028)
7.3.2 North America Anti Snake Venom Serum (ASVS) Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Anti Snake Venom Serum (ASVS) Sales by Type (2017-2028)
8.2 Europe Anti Snake Venom Serum (ASVS) Sales by Application (2017-2028)
8.3 Europe Anti Snake Venom Serum (ASVS) Market Size by Country
8.3.1 Europe Anti Snake Venom Serum (ASVS) Sales in Volume by Country (2017-2028)
8.3.2 Europe Anti Snake Venom Serum (ASVS) Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Anti Snake Venom Serum (ASVS) Sales by Type (2017-2028)
9.2 Asia-Pacific Anti Snake Venom Serum (ASVS) Sales by Application (2017-2028)
9.3 Asia-Pacific Anti Snake Venom Serum (ASVS) Market Size by Region
9.3.1 Asia-Pacific Anti Snake Venom Serum (ASVS) Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Anti Snake Venom Serum (ASVS) Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Anti Snake Venom Serum (ASVS) Sales by Type (2017-2028)
10.2 South America Anti Snake Venom Serum (ASVS) Sales by Application (2017-2028)
10.3 South America Anti Snake Venom Serum (ASVS) Market Size by Country
10.3.1 South America Anti Snake Venom Serum (ASVS) Sales in Volume by Country (2017-2028)
10.3.2 South America Anti Snake Venom Serum (ASVS) Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Anti Snake Venom Serum (ASVS) Sales by Type (2017-2028)
11.2 Middle East & Africa Anti Snake Venom Serum (ASVS) Sales by Application (2017-2028)
11.3 Middle East & Africa Anti Snake Venom Serum (ASVS) Market Size by Country
11.3.1 Middle East & Africa Anti Snake Venom Serum (ASVS) Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Anti Snake Venom Serum (ASVS) Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Anti Snake Venom Serum (ASVS) and Key Manufacturers
12.2 Manufacturing Costs Percentage of Anti Snake Venom Serum (ASVS)
12.3 Anti Snake Venom Serum (ASVS) Production Process
12.4 Anti Snake Venom Serum (ASVS) Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Anti Snake Venom Serum (ASVS) Typical Distributors
13.3 Anti Snake Venom Serum (ASVS) Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer